Reuters logo
BRIEF-Cadila Healthcare says Zydus Cadila gets USFDA nod for Mesalamine delayed-release tablets
June 7, 2017 / 4:06 AM / 4 months ago

BRIEF-Cadila Healthcare says Zydus Cadila gets USFDA nod for Mesalamine delayed-release tablets

June 7 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus Cadila gets USFDA final approval for Mesalamine delayed-release tablets USP, 1.2 g.

* Says product will be manufactured at the Moraiya manufacturing facility for the US market Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below